HOME >> MEDICINE >> NEWS
Could reality TV save academic medicine?

Imagine a future where medical schools are answerable to shareholders, where patients decide how doctors should be trained, or where academics compete on TV game shows to win research grants

This could be the future of academic medicine by 2025, according to members of the International Campaign to Revitalise Academic Medicine (ICRAM), launched by the BMJ and partners in November 2003.

Their vision for the future is published simultaneously today by the BMJ (www.bmj.com), the open access international medical journal PLoS Medicine (www.plosmedicine.org) and the Milbank Memorial Fund (www.milbank.org).

In the first scenario, academic medicine flourished in the private sector and medical research, training and service became commercial business activities. But, although overall efficiency and effectiveness improved, equity and innovation suffered.

Academic medicine disappeared altogether in the second scenario. Instead, teaching, learning, and researching were integrated with mainstream health care. Team work fostered, but stability and decision making was threatened.

In scenario three, the public were in charge. They determined research priorities through game shows or citizen's juries and students received most of their training from expert patients. But scientific advances were subject to fads and there was little regulation of health information.

In the final two scenarios, academic medicine engaged fully with all stakeholders and focused on improving global health. Global networks flourished and medical training was energised. But lack of political will and fears of "dumbing down" hampered progress.

"None of these scenarios will come to exist as we have described them, but the future is likely to contain some elements from each of them," say the authors. "Our main hope is that o
'"/>

Contact: Paul Ocampo
press@plos.org
415-624-1224
Public Library of Science
4-Jul-2005


Page: 1 2

Related medicine news :

1. Could statins be a new option for hepatitis C patients?
2. Could the ability to expel worms lead to a future asthma treatment?
3. Could dental disease contribute to increased risk of stroke?
4. Could a popular HIV drug benefit hepatitis B patients?
5. Could a simple test save Medicare hundreds of millions?
6. Could exercise protect older people from hip fracture?
7. Cant serve an ace? Could be muscle fatigue
8. Social connections: Could heartwarming be heart-saving?
9. Our grip on reality is slim, says UCL scientist
10. The $6 billion (hu)man is becoming reality, as bionics restores or expands humans abilities
11. Fringe plastic surgery procedures more hype than reality, ASPS says

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Could reality save academic medicine

(Date:1/22/2015)... York, New York (PRWEB) January 22, 2015 ... http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District of ... C.R. Bard, Inc. in that proceeding’s first bellwether trial. In ... request for a new trial after finding that C.R. Bard ...
(Date:1/22/2015)... 20 years, Dr. David Cruz of Cruz Chiropractic Care ... about every type of injury that can result from car accidents ... years, the team at Doctors on Liens has been ... With the combined breadth of experience between the two, ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne wedding ... revenues in the past three years. Today, the business announces ... According to the sales manager of the company, this is ... 2015. This point can be reflected on the discounted wedding ...
(Date:1/22/2015)... January 22, 2015 As interest in the ... care gains momentum worldwide, Rev. Eric J. Hall , ... Network (HCCN), will be the keynote speaker on January ... Israel’s public health system. , The conference, “Hope and Resilience: ...
(Date:1/22/2015)... 2015 State Forestry Institute of Mecklenburg-Vorpommern ... with support from GEOSYSTEMS, a dedicated Hexagon Geospatial and ... leverage Hexagon Geospatial’s ERDAS APOLLO for cataloging, ... as point clouds and documents. This effort will enable ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
(Date:1/23/2015)... Gem Pharmaceuticals announced today that the initial soft tissue ... Phase 2 clinical trial.  This open-label study will assess ... (an investigational medication), in approximately 30 adults as first-line ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO GPX-150 is ...
(Date:1/22/2015)...  BiOptix is pleased to announce the appointment of Dr. ... and Biochemistry. Scott joins the company after previous scientific leadership ... the course of his nearly 20 year career in ... nationally recognized thought leader in the biosensor field and ...
(Date:1/22/2015)... THOUSAND OAKS, Calif. , Jan. 22, 2015  Amgen (NASDAQ: ... quarter and full year 2014 financial results on Tuesday, Jan. 27, ... will be followed by a conference call with the investment community ... be Robert A. Bradway , chairman and chief executive officer, ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2
Cached News: